Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia-Reference-Cited by-同舟云学术

Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia

Published:2010-07-22 Issue:9 Volume:85 Page:670-674
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Ghobrial Irene M.,Xie Wanling,Padmanabhan Swaminathan,Badros Ashraf,Rourke Meghan,Leduc Renee,Chuma Stacey,Kunsman Janet,Warren Diane,Poon Tiffany,Harris Brianna,Sam Amy,Anderson Kenneth C.,Richardson Paul G.,Treon Steven P.,Weller Edie,Matous Jeffrey

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.21788/fullpdf

Reference22 articles.

1. Waldenstrom's macroglobulinemia: Clinical features, complications, and management;Dimopoulos;J Clin Oncol,2000

2. Waldenstrom macroglobulinemia;Ghobrial;Curr Treat Options Oncol,2004

3. Diagnosis and management of Waldenstrom's macroglobulinemia;Dimopoulos;J Clin Oncol,2005

4. Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia;Owen;Semin Oncol,2003

5. Waldenstrom macroglobulinaemia;Ghobrial;Lancet Oncol,2003

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness, safety, and tolerability of delayed dexamethasone, rituximab, and cyclophosphamide as first-line treatment in patients with Waldenström macroglobulinemia: data from the Sicilian Myeloma Network;Frontiers in Hematology;2024-06-20

2. Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia;Leukemia;2024-02-26

3. Rituximab plus cyclophosphamide and dexamethasone <i>versus</i> bortezomib plus cyclophosphamide and dexamethasone in newly diagnosed symptomatic Waldenström macroglobulinemia: a randomized controlled trial;Haematologica;2024-01-11

4. Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-01

5. Waldenstrom Macroglobulinemia;Comprehensive Hematology and Stem Cell Research;2024